Dengue Virus Type 4 Envelope Protein, Recombinant, aa280-674, His-Tag (Dengue Type 4 EP)
Catalog No : USB-367962
1149.46€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | Dengue Virus Type 4 Envelope Protein, Recombinant, aa280-674, His-Tag (Dengue Type 4 EP) | ||
|---|---|---|---|
| Catalog No | USB-367962 | ||
| Supplier’s Catalog No | 367962 | ||
| Supplier | US Biologicals | ||
| Source antigen | Recombinant, Drosophila | ||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | 50 | ||
| Storage | -20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Purified | ||
| Purity | ~85% (SDS-PAGE) | ||
| Form | Supplied as a liquid in PBS, pH 7.4, 0.09% sodium azide. | ||
| Reactivity life | 12 months | ||
| Note | For reserch purpose only | ||
| Purity | ~85% (SDS-PAGE) | ||
| Description | Dengue virus is common mosquito-borne infection and a major cause of morbidity in tropical and subtropical regions. There is currently no vaccine to prevent, or effective anti-viral drugs to treat, dengue virus infection. In many cases infection is assymptomatic and the majority of individuals who get ill only suffer the mild, non-specific febrile symptoms characteristic of dengue fever (DF). Only a minority of infections result in severe disease, manifesting as dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS). Dengue virus infection gives lifelong immunity to the serotype in question but subsequent infection with another serotype may increase the likelihood of severe disease. Source: Recombinant protein corresponding to aa280-674 from Dengue Type 4 Envelope Protein, fused to His-tag, expressed in Drosophila. Molecular Weight: ~50kD Applications: Suitable for use in ELISA and Lateral Flow. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. | ||
Product Details
© 2020 Imugex All Rights Reserved